相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Mauro Di Ianni et al.
BLOOD (2011)
Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells
Jakub Tolar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Rapamycin enhances lifespan: At last, an advantage for transplant recipients?
Edward K. Geissler
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin
Laura Strauss et al.
PLOS ONE (2009)
Rapamycin-treated mature dendritic cells have a unique cytokine secretion profile and impaired allostimulatory capacity
Guo-Ying Wang et al.
TRANSPLANT INTERNATIONAL (2009)
Mechanisms regulating the development and function of natural regulatory T cells
Sonal Gupta et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-Cells
Paolo Monti et al.
DIABETES (2008)
Critical role of IL-2 and TGF-β in generation, function and stabilization of Foxp3+CD4+ Treg
David A. Horwitz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
IL-2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells
Susan Brandenburg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
IL-2 signaling and CD4(+)CD25(+)Foxp3(+) regulatory T cells
Laurence A. Turka et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Combination of rapamycin and IL-2 increases de novo induction of human CD4+CD25+FOXP3+ T cells
S. Alice Long et al.
JOURNAL OF AUTOIMMUNITY (2008)
De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR
Johnthomas Kang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Novel Approaches to Imatinib-and Sunitinib-Resistant GIST
Peter Reichardt
CURRENT ONCOLOGY REPORTS (2008)
Differential impact of mammalian target of rapamycin inhibition on CD4(+)CD25(+)Foxp3(+) regulatory T cells compared with conventional CD4(+) T cells
Robert Zeiser et al.
BLOOD (2008)
Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+T regulatory cells
Heather Kopf et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
CXCL 10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation
Karen P. Piper et al.
BLOOD (2007)
The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice
Yanyan Qu et al.
TRANSPLANT IMMUNOLOGY (2007)
Selective survival of naturally occurring human CD4(+)CD25(+)Foxp3(+) regulatory T cells cultured with rapamycin
Laura Strauss et al.
JOURNAL OF IMMUNOLOGY (2007)
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients
Manuela Battaglia et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
Emmanuel Zorn et al.
BLOOD (2006)
Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells
Danila Valmori et al.
JOURNAL OF IMMUNOLOGY (2006)
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
Robert Zeiser et al.
BLOOD (2006)
IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
M Ahmadzadeh et al.
BLOOD (2006)
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
E Zorn et al.
BLOOD (2005)
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease
DR Couriel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
M Battaglia et al.
BLOOD (2005)
Regulation of CD4+CD25+ regulatory T cell activity:: it takes (IL-)two to tango
A Scheffold et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease
LJ Johnston et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Shifting foci of hematopoiesis during reconstitution from single stem cells
YA Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tolerance, not immunity, crucially depends on IL-2
TR Malek et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Interleukin-2 is essential for CD4+CD25+ regulatory T cell function
M de la Rosa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Cutting edge:: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function
AM Thornton et al.
JOURNAL OF IMMUNOLOGY (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells
SJ Bensinger et al.
JOURNAL OF IMMUNOLOGY (2004)
Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance
A Antov et al.
JOURNAL OF IMMUNOLOGY (2003)
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
JH Antin et al.
BLOOD (2003)
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging
M Edinger et al.
BLOOD (2003)
Inhibition of IL-12 signaling Stat4/IFN-γ pathway by rapamycin is associated with impaired dendritc cell function
PH Chiang et al.
TRANSPLANTATION PROCEEDINGS (2002)
CD4+CD25high regulatory cells in human peripheral blood
C Baecher-Allan et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
